Walter J. Curran, MD, on Stage III NSCLC

Posted: Monday, March 20, 2017

Walter J. Curran, MD, of Emory University, summarizes his keynote address on clinical trials in non-small cell lung cancer—lessons learned and the path forward with targeted treatments and checkpoint inhibitors in combination with radiation and chemotherapy.